Challenge trials have long history, going back to development of smallpox vaccine in 1796
No COVID-19 Vaccines Allowed in California Without State Approval
California governor says vaccinations ‘will move at the speed of trust’
Inactivated SARS-CoV-2 Vaccine Well Tolerated in Phase 1/2 Trial
Neutralizing antibody geometric mean titers higher in vaccine group at day 42 in phase 1 trial
No Pfizer COVID-19 Vaccine Expected Before Election
Company has reversed its previous claims that it would apply for the approval in October
NIH Launches Trial of Antibody Drugs Against COVID-19
The phase 2 trial will assess effectiveness of monoclonal antibodies in conjunction with remdesivir
Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes
COVID-19 Antibody Treatment Study Paused
ACTIV-3 study, testing use of an antibody therapy with remdesivir, paused ‘out of an abundance of caution’
Second COVID-19 Vaccine Trial Paused for Unexplained Illness
Johnson & Johnson stopped its COVID-19 vaccine trial, which began phase 3 testing last month
CDC: U.S. COVID-19 Deaths Could Reach 233,000 by End of October
And, dual coronavirus-flu vaccine to start human trials
Remdesivir Cuts Time to COVID-19 Recovery
However, no significant difference in mortality found between remdesivir and placebo groups
- Page 2 of 2
- 1
- 2